Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

LUFI-500 TABLET 500mg

Approval Number

SIN14808P

Drug Name

LUFI-500 TABLET 500mg

Product Name

LUFI-500 TABLET 500mg

Approval Date

July 15, 2015

Registrant

ZYFAS PHARMA PTE LTD

Licence Holder

ZYFAS PHARMA PTE LTD

Regulatory Information

Registrant

ZYFAS PHARMA PTE LTD

Licence Holder

ZYFAS PHARMA PTE LTD

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

TABLET, FILM COATED

Route of Administration

ORAL

Medical Information

ATC Code

J01MA12

ATC Item Name

levofloxacin

Manufacturer Information

Pharmaceutical Manufacturer

ZYFAS PHARMA PTE. LTD.

Manufacturers

Ipca Laboratories Limited

Active Ingredients

Ingredient Name

Levofloxacin hemihydrate. 518.52 mg equivalent to Levofloxacin

Strength

500mg

Drug MonographLevofloxacin

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

LUFI-500 TABLET 500mg - HSA Approval | MedPath